SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Xetra Frankfurt
Börse Xetra Frankfurt
ISIN US717081ER06
EUR
  • Pfizer
    Börse NYSE New York Stock Exchange
    ISIN US7170811035 WKN: 852009
    Symbol PFE
    USD
  • PFIZER INC
    Börse Börse Hamburg
    ISIN US717081ED10
    Symbol PFE
    EUR
  • Pfizer
    Börse Börse Stuttgart
    ISIN US717081DK61
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081ER06
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Düsseldorf
    ISIN XS1574158082
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse München
    ISIN US717081DZ31
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Gettex System der Börse München
    ISIN US717081ES88
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Tradegate System der Deutsche Börse AG (60%)
    ISIN US717081EQ23
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Quotrix System der Börse Düsseldorf
    ISIN US717081DE02
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Frankfurt
    ISIN XS1574157357
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081EY56
    EUR
  • Pfizer
    Börse Börse München
    ISIN US717081FA61
    EUR
  • Pfizer
    Börse SSE Stockholm Stock Exchange
    ISIN US717081EZ22
    Symbol PFE
    SEK
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081EK52
    Symbol PFE
    MXN
  • Pfizer
    Börse Bolsa de Comercio de Buenos Aires
    ISIN US717081DV27
    USD
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081DH33
    MXN
  • Pfizer
    Börse BUE
    ISIN US717081EV18
    USD
  • ISIN US717081EX73
    Symbol PFE
    EUR
  • Pfizer
    Börse OMXS
    ISIN US7170811035
    SEK
  • ISIN US717081EJ89
    EUR
  • PFIZER INC
    Börse SSE
    ISIN US717081EP40
ISIN US717081ER06
Symbol PFE
Währung EUR
Börse Xetra Frankfurt Zeitzone: Europe/Berlin
Firmenname Pfizer Inc
Marktkapitalisierung 197.500.079.920 (+- 10%)

Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:

204.882.624.512 oder 216.419.000.000 oder 171.198.615.249

Mitarbeiter 83.400 (+- 6%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

88.300 oder 78.500 Mitarbeiter

Anzahl Aktien 5.558.396.599
KGV 18.68 (+- 28%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

23.97 oder 13.4

EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744

Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39  . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht

Analystenmeinungen

Übersicht

Letzte Communitymeinungen

Ein User hat Pfizer abonniert.

Aktionärsstruktur der Pfizer Inc

1.790 News & Informationen zur Pfizer Aktie

  • Tandem Investment Advisors, Inc. Buys Fiserv Inc, CVS Health Corp, Coca-Cola Co, Sells Raytheon Technologies Corp, Expeditors International...
    gurufocus.com

    Tandem Investment Advisors, Inc. Buys Fiserv Inc, CVS Health Corp, Coca-Cola Co, Sells Raytheon Technologies Corp, Expeditors International of Washington Inc, Carter Bankshares Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Ferguson Wellman Capital Management, Inc Buys Fortinet Inc, UnitedHealth Group Inc, Pfizer Inc, Sells The Walt Disney Co, Amgen Inc,...
    gurufocus.com

    Ferguson Wellman Capital Management, Inc Buys Fortinet Inc, UnitedHealth Group Inc, Pfizer Inc, Sells The Walt Disney Co, Amgen Inc, Rockwell Automation Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Israel Begins Pfizer Booster Shots for At-Risk Adults as Delta Cases Rise
    online.wsj.com

    Israel Begins Pfizer Booster Shots for At-Risk Adults as Delta Cases Rise

    Israel’s health ministry said a third dose of the Pfizer vaccine would be offered to people who are immunocompromised, including those who have undergone organ transplants.

  • DoH rules out booster jabs
    manilatimes.net

  • Precision Medicine Market Size Worth USD 126.14 Billion by 2025 at 12.48% CAGR – Report by Market Research Future (MRFR)
    globenewswire.com

    Precision Medicine Market Size Worth USD 126.14 Billion by 2025 at 12.48% CAGR – Report by Market Research Future (MRFR)

    Precision Medicine Market Insights and Industry Analysis by Therapeutics (Cancer/Oncology, Cardiovascular Disease (CVD), Infectious Diseases, Central…

  • In world's first, this country to administer mix of Sinovac and Astra Covid jabs
    livemint.com

    In world's first, this country to administer mix of Sinovac and Astra Covid jabs

    The decision is based on three separate local studies, which showed that following Sinovac with Astra elicited an immune response that’s as high as using two doses of Astra 12 weeks apart

  • Fauci says COVID-19 vaccine boosters not needed for now, as delta variant mostly infecting the unvaccinated
    marketwatch.com

    Fauci says COVID-19 vaccine boosters not needed for now, as delta variant mostly infecting the unvaccinated

    Dr. Anthony Fauci, chief medical adviser to President Joe Biden, did the round of Sunday talk shows on Sunday to say COVID-19 vaccine boosters are not needed…

  • Valuation in Geriatric Medicines Market to Reach US$ 1142.8 Bn by 2027, Use in Managing Cardiovascular Diseases Spurs Growth: TMR
    prnewswire.com

    Valuation in Geriatric Medicines Market to Reach US$ 1142.8 Bn by 2027, Use in Managing Cardiovascular Diseases Spurs Growth: TMR

    /PRNewswire/ — Geriatrics care has made enormous strides over the past few decades. Rapidly aging populations notably in some emerging economies and developed…

  • Valuation In Geriatric Medicines Market To Reach US$ 1142.8 Bn By 2027, Use In Managing Cardiovascular Diseases Spurs Growth: TMR
    thestreet.com

    Valuation In Geriatric Medicines Market To Reach US$ 1142.8 Bn By 2027, Use In Managing Cardiovascular Diseases Spurs Growth: TMR

    ALBANY, N.Y., July 12, 2021 /PRNewswire/ — Geriatrics care has made enormous strides over the past few decades. Rapidly aging populations notably in some

  • 5 things to know before the stock market opens Monday
    cnbc.com

    5 things to know before the stock market opens Monday

    Dow futures dropped, indicating a retreat for the 30-stock average from Friday's record high close.

  • Acute Kidney Failure Treatment Market 2021 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Analysis, Forecast Report
    globenewswire.com

    Acute Kidney Failure Treatment Market 2021 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Analysis, Forecast Report

    Top Players Covered in the Acute Kidney Failure Treatment Market Research Report are Fresenius Medical Care, B. Braun Melsungen AG, Pfizer Inc., Medtronic,…

  • Avanos Medical : Inc. Appoints Moji James as Senior Vice President & General Counsel
    marketscreener.com

    Avanos Medical : Inc. Appoints Moji James as Senior Vice President & General Counsel

    ALPHARETTA, Ga., July 12, 2021 /PRNewswire/ — Avanos Medical, Inc. today announced that Moji James has been appointed senior vice president & general counsel. In this role, James will… | July 12, 2021

  • 3 Dirt-Cheap Robinhood Stocks
    fool.com

  • Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance
    globenewswire.com

    Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance

    Dr. Zhang has over 20 years of experience in regulatory affairs, with over a decade specifically in the field of cell and gene therapy…

  • Pfizer/BioNTech bid for booster doses premature, more data needed
    investing.com

    Pfizer/BioNTech bid for booster doses premature, more data needed

    Analysis – Pfizer/BioNTech bid for booster doses premature, more data needed – experts

  • Pfizer Shares Likely To Get A Boost In The Second Half Of 2021 (NYSE:PFE)
    seekingalpha.com

    Pfizer Shares Likely To Get A Boost In The Second Half Of 2021 (NYSE:PFE)

    Pfizer appears likely to break out of its multi-year trading range. Its exposure to Covid-19 vaccine appears underappreciated, which is likely to correct in second half of 2021.

  • U.S. administers nearly 334.2 million doses of COVID-19 vaccines: CDC By Reuters
    investing.com

    U.S. administers nearly 334.2 million doses of COVID-19 vaccines: CDC By Reuters

    U.S. administers nearly 334.2 million doses of COVID-19 vaccines: CDC

  • Late-Stage Clinical Study Readouts Biotech Investors Should Watch
    fool.com

    Late-Stage Clinical Study Readouts Biotech Investors Should Watch

    Several drugmakers have important clinical trial updates on the way.

  • Pfizer, U.S. health officials to discuss COVID boosters on Monday -company By Reuters
    investing.com

    Pfizer, U.S. health officials to discuss COVID boosters on Monday -company By Reuters

    Pfizer, U.S. health officials to discuss COVID boosters on Monday -company

  • Tech Firms to Buy Covid-19 Vaccines on Behalf of Taiwan’s Government
    online.wsj.com

    Tech Firms to Buy Covid-19 Vaccines on Behalf of Taiwan’s Government

    The roundabout arrangement with TSMC and Foxconn effectively ends a monthslong geopolitical impasse over whether Taiwan could buy vaccines directly from BioNTech.

  • These 5 Mid-Cap ETFs Are Worth Adding to Your Portfolio Now
    investing.com

    These 5 Mid-Cap ETFs Are Worth Adding to Your Portfolio Now

    Stocks Analysis by Zacks Investment Research covering: Pfizer Inc, AstraZeneca PLC ADR. Read Zacks Investment Research's latest article on Investing.com

  • 3 Robinhood Stocks to Buy Right Now That Are Better Than Bitcoin
    fool.com

  • Pfizer: mRNA Vaccines Not A Flash In The Pan (NYSE:PFE)
    seekingalpha.com

    Pfizer: mRNA Vaccines Not A Flash In The Pan (NYSE:PFE)

    Pfizer/BioNTech COVID vaccine dominating global supply and dramatically distorting Pfizer’s business. The mRNA technology is a huge opportunity. Read more here…

  • TSMC, Foxconn say they are in process of signing deal for BioNTech COVID-19 vaccines By Reuters
    investing.com

    TSMC, Foxconn say they are in process of signing deal for BioNTech COVID-19 vaccines By Reuters

    TSMC, Foxconn say they are in process of signing deal for BioNTech COVID-19 vaccines

  • U.S. administers nearly 333.6 million doses of COVID-19 vaccines- CDC By Reuters
    investing.com

    U.S. administers nearly 333.6 million doses of COVID-19 vaccines- CDC By Reuters

    U.S. administers nearly 333.6 million doses of COVID-19 vaccines- CDC

  • The Curious Case Of Elliott Advisors And GSK: Are Activist Investors What They Used To Be?
    forbes.com

    The Curious Case Of Elliott Advisors And GSK: Are Activist Investors What They Used To Be?

    Elliott Advisors supports GSK's plans to split into two companies and has made five recommendations. One is that a refreshed board do an internal and external search for the CEO of New GSK. Many are interpreting this as an attack on CEO Emma Walmsley. It is not. It is just good corporate governance.

  • Australia’s Delta Outbreak Shows Vaccines Protect Against Hospitalization
    online.wsj.com

    Australia’s Delta Outbreak Shows Vaccines Protect Against Hospitalization

    Early data from Australia’s outbreak of the Covid-19 Delta variant suggest that two vaccine doses offer significant protection against severe illness and hospitalization.

  • French health regulator recommends compulsory COVID-19 shots for health workers By Reuters
    investing.com

    French health regulator recommends compulsory COVID-19 shots for health workers By Reuters

    French health regulator recommends compulsory COVID-19 shots for health workers

  • Facebook, JPMorgan Chase, Netflix: Stocks That Defined the Week
    online.wsj.com

    Facebook, JPMorgan Chase, Netflix: Stocks That Defined the Week

    Here are seven major companies whose stocks moved on the week’s news.

  • Worldwide Infusion Therapy Industry To 2026 - Rapid Technological Innovations Present Opportunities
    thestreet.com

    Worldwide Infusion Therapy Industry To 2026 – Rapid Technological Innovations Present Opportunities

    DUBLIN, July 9, 2021 /PRNewswire/ — The “Infusion Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026” report has been

  • Pfizer- und BioNTech-Aktien steigen: Auffrischungs-Impfung wahrscheinlich erforderlich
    finanzen.net

    Pfizer- und BioNTech-Aktien steigen: Auffrischungs-Impfung wahrscheinlich erforderlich

    Die Impfstoffhersteller Pfizer und BioNTech gehen von einem Rückgang der Schutzwirkung des gemeinsamen Coronavirus-Vakzins nach einem halben Jahr aus. 09.07.2021

  • Moderna : Saudi Arabia approves Moderna's COVID vaccine -state news agency
    marketscreener.com

    Moderna : Saudi Arabia approves Moderna's COVID vaccine -state news agency

    Saudi Arabia's Food and Drug
    Authority on Friday approved Moderna Inc's COVID-19 vaccine
    for use in the kingdom, the state news agency
    said.
    The authority added that after this… | July 9, 2021

  • U.S. administers nearly 333 million doses of COVID-19 vaccines
    investing.com

    U.S. administers nearly 333 million doses of COVID-19 vaccines

    U.S. administers nearly 333 million doses of COVID-19 vaccines – CDC

  • EU finds potential link between heart inflammation and mRNA COVID shots By Reuters
    investing.com

    EU finds potential link between heart inflammation and mRNA COVID shots By Reuters

    EU finds potential link between heart inflammation and mRNA COVID shots

  • MÄRKTE EUROPA/Kräftiges Plus - BASF und VW überraschen positiv
    finanzen.net

    MÄRKTE EUROPA/Kräftiges Plus – BASF und VW überraschen positiv

    MÄRKTE EUROPA/Kräftiges Plus – BASF und VW überraschen positiv | Nachricht | finanzen.net

  • Why Shares of Pfizer Are Rising Today
    fool.com

    Why Shares of Pfizer Are Rising Today

    The company is laying out a timeline for vaccine boosters as the Delta variant takes over.

  • BioNTech (BNTX)/ Pfizer to Seek FDA Nod for COVID-19 Booster
    zacks.com

    BioNTech (BNTX)/ Pfizer to Seek FDA Nod for COVID-19 Booster

    BioNTech (BNTX) and partner Pfizer plan to get authorization for COVID-19 booster vaccine shot in the United States owing the emerging Delta variant of the virus.

  • BioRevolution Development—Intellia’s CRISPR Study News
    wisdomtree.com

    BioRevolution Development—Intellia’s CRISPR Study News

    WisdomTree is an ETF sponsor and index developer that uses a rules-based methodology to select and weight companies. Learn more about specialized ETFs here.

  • Active Pharmaceutical Ingredients Market Worth USD 312 Billion by 2028 at 6.2% CAGR - Report by Market Research Future (MRFR)
    globenewswire.com

    Active Pharmaceutical Ingredients Market Worth USD 312 Billion by 2028 at 6.2% CAGR – Report by Market Research Future (MRFR)

    Active Pharmaceutical Ingredients Market Insights and Industry Analysis by Type of Synthesis (Biotech and Synthetic), By Molecules (Large Molecule and…

  • U.S. Covid-19 hospitalizations rise as Delta Variant spreads
    livemint.com

    U.S. Covid-19 hospitalizations rise as Delta Variant spreads

    Daily admissions rose 6.8% after long decline, while outbreaks among unvaccinated pushed up new cases

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Pfizer Aktie

Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.

Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.

Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect